论文部分内容阅读
目的 探究氨溴特罗联合复方异丙托溴铵辅助治疗小儿肺炎的临床效果.方法 于2020年1月～2020年6月收治60例肺炎患儿为研究对象,随机分组,各30例,对照组采用常规治疗,观察组采用常规治疗+氨溴特罗联合复方异丙托溴铵.两组治疗效果比较.结果 观察组治疗总有效率93.33％(28/30)高于对照组总有效率73.33％(22/30),差异显著(P ＜ 0.05).结论 采用在常规治疗的基础上采用氨溴特罗联合复方异丙托溴铵辅助治疗可获得更加满意的疗效,值得临床推广.“,”Objective To explore the clinical effect of ambroxol combined with compound ipratropium bromide in the adjuvant treatment of infantile pneumonia. Methods From January 2020 to June 2020, 60 children with pneumonia were randomly divided into two groups, 30 cases in each group. The control group was treated with conventional treatment, and the observation group was treated with conventional treatment + ambroxol combined with compound ipratropium bromide. The treatment effect of the two groups was compared. Results The total effective rate of the observation group was 93.33％(28/30), which was higher than 73.33％ (22/30) of the control group (P＜0.05). Conclusion On the basis of conventional treatment, ambroxol combined with compound ipratropium bromide can obtain more satisfactory curative effect, which is worthy of clinical promotion.